Table 1.
Baseline clinical characteristics of patients with diffuse large B-cell lymphoma according to lymphocyte-to-monocyte ratio.
Figure 1.
ROC curves analysis for AMC, ALC, and LMR at diagnosis in the training set. A:
ROC curves analysis for AMC at diagnosis in the training set. B: ROC curves analysis for ALC at diagnosis in the training set. C: ROC curves analysis for LMR at diagnosis in the training set. ROC, receiver operating characteristic; AMC, absolute monocyte count; ALC, absolute lymphocyte count; LMR, lymphocyte-to-monocyte ratio.
Figure 2.
Kaplan-Meier survival analysis of LMR at diagnosis in patients with diffuse large B-cell lymphoma. A:
Overall survival according to baseline LMR in the testing set. B: Progression-free survival according to baseline LMR in the testing set. C: Overall survival according to baseline LMR in all patients. D: Progression-free survival according to baseline LMR in all patients. LMR, lymphocyte-to-monocyte ratio.
Figure 3.
Kaplan-Meier survival analysis of baseline LMR in patients with IPI = 0–1 or IPI ≥2.
A: Overall survival of patients with IPI = 0–1 in the testing set. B: Progression-free survival of patients with IPI = 0–1 in the testing set. C: Overall survival of patients with IPI ≥2 in the testing set. D: Progression-free survival of patients with IPI ≥2 in the testing set. E: Overall survival of patients with IPI = 0–1 in all patients. F: Progression-free survival of patients with IPI = 0–1 in all patients. G: Overall survival of patients with IPI ≥2 in all patients. H: Progression-free survival of patients with IPI score ≥2 in all patients. LMR, lymphocyte-to-monocyte ratio; IPI, International Prognostic Index.
Table 2.
Multivariate analysis of prognostic factors for survival in testing set.
Table 3.
Multivariate analysis of prognostic factors for survival in all patients with diffuse large B-cell lymphoma.